Searchable abstracts of presentations at key conferences in endocrinology

ea0063p781 | Thyroid 2 | ECE2019

Iodine and selenium status in adult PKU

Sumanszki Csaba , Kiss Erika , Simon Erika , Galgoczi Erika , Soos Aron , Patocs Attila , Kovacs Bela , Nagy Endre V , Reismann Peter

Background: The standard, lifelong therapy of phenylketonuria (PKU) is natural protein-restricted diet completed with Phenylalanine (Phe)-free L-amino acid mixtures that provide the daily necessary micronutrients, such as iodine and selenium. Our main objective in this study was to assess the iodine and selenium status of patients with PKU, based on their adherence to the low-Phe diet, compared to a healthy control group. Secondly, we aimed to asses whether adherence to therap...

ea0041gp114 | Endocrine Tumours | ECE2016

Proteomic and pathway analysis of adrenocortical cancer in an in vivo xenograft study

Nagy Zoltan , Baghy Kornelia , Hunyadi-Gulyas Eva , Decmann Abel , Kovalszky Ilona , Medzihradszky Katalin , Racz Karoly , Patocs Attila , Igaz Peter

Background: Few effective medical treatment options are available for adrenocortical carcinoma (ACC). Intensive efforts are therefore going on for exploring novel pathways and treatment targets.Objective: To perform a proteomic and pathway analysis on a 9-cisRA (9-cis retinoic acid) and mitotane-treated ACC xenograft model.Methods: 43 male SCID mice xenografted with NCI-H295R cells were treated in four groups (i. control, ii. 5 mg/...

ea0037gp.18.06 | Pituitary–Basic and IGF-1 | ECE2015

Comparison of high-throughput platforms in evaluation of whole genome miRNA expression profiles in pituitary tissues

Butz Henriett , Darvasi Otto , Szabo Peter M , Liko Istvan , Pongor Lorinc , Czirjak Sandor , Racz Karoly , Patocs Attila

Introduction: There are three principal high-throughput methods that have been widely used to determine whole genome miRNAs expression profiles: i) microarrays, ii) qPCR based arrays, and iii) next generation sequencing (NGS). Our aim was to compare the results obtained from these platforms in normal and adenomatous pituitary samples and to validate the results by an independent sample set using qPCR.Material and methods: Using four normal pituitary (NP)...

ea0037gp.29.04 | Endocrine tumours and neoplasia – Adrenal Tumour | ECE2015

Synergistic action of 9-cis retinoic acid and mitotane in a H295R adrenocortical cancer xenograft model

Nagy Zoltan , Baghy Kornelia , Szabo Peter M , Kovalszky Ilona , Perge Pal , Patocs Attila , Racz Karoly , Igaz Peter

Background: Current drug treatment options for adrenocortical carcinoma (ACC) are rather limited and intensive efforts are going on to find novel effective agents. In our previous functional genomics study, retinoid signalling via the retinoid X receptor (RXR) was identified as a major pathogenic pathway in ACC and we have demonstrated the in vitro activity of 9-cis retinoic acid (9-cisRA) acting via the RXR on NCI-H295R cells and also found that 9-cisRA has antitumou...

ea0032oc4.6 | Adrenal | ECE2013

9-cis retinoic acid, a novel treatment option for adrenocortical cancer? in vitro and in vivo studies

Szabo Diana Rita , Baghy Kornelia , Szabo Peter M , Falus Andras , Kovalszky Ilona , Patocs Attila , Racz Karoly , Igaz Peter

Background: The medical treatment options of adrenocortical cancer are limited. In our previous meta-analysis of adrenocortical tumor genomics data, adrenocortical cancer was found to be associated with reduced retinoic acid production and retinoid X receptor-mediated signaling.Objective: To study the potential antitumoral effects of 9-cis-retinoic acid (9-cisRA) on the adrenocortical cancer cell line NCI-H295R and in a xenograft model....

ea0022p32 | Adrenal | ECE2010

Utility of midnight salivary cortisol measurement in the diagnosis of overt and subclinical Cushing's syndrome

Sereg Marta , Toke Judit , Patocs Attila , Igaz Peter , Szucs Nikolett , Varga Ibolya , Szappanos Agnes , Glaz Edit , Racz Karoly , Toth Miklos

Background: Midnight salivary cortisol (SalC2400) measurement has been recently suggested as one of the first-line screening tests for hypercortisolism.Aims: In our present study, we evaluated the clinical utility of the salivary cortisol (SalC) measurement in the diagnosis of both overt and subclinical Cushing’s syndrome.Patients and methods: Patients with overt Cushing’s syndrome (n=23, group A) and those with su...

ea0016p676 | Steroid receptors | ECE2008

Glucocorticoid receptor gene polymorphisms in patients with Cushing's disease and adrenal Cushing's syndrome

Szappanos Agnes , Patocs Attila , Toke Judit , Sereg Marta , Futo Laszlo , Kende Zoltan , Varga Ibolya , Glaz Edit , Racz Karoly , Toth Miklos

Introduction: The hypothalamic–pituitary–adrenal axis setpoint and the glucocorticoid sensitivity in various tissues are at least partly genetically determined. The glucocorticoid receptor (GR) gene polymorphisms may have an impact on the development and/or the variability of clinical manifestations of endogenous hypercortisolism, however their role has not been investigated in patients with endogenous hypercortisolism.Methods: We investigated ...

ea0056gp37 | Adrenal cortex | ECE2018

MicroRNA expression profiling in adrenal myelolipoma, adrenocortical cancer and adrenocortical adenoma

Decmann Abel , Perge Pal , Nyiro Gabor , Darvasi Otto , Liko Istvan , Borka Katalin , Micsik Tamas , Patocs Attila , Igaz Peter

Background: Adrenal myelolipoma (AML) is a relatively common and invariably benign tumor composed of adipose tissue and hematopoietic elements. Due to the variable proportion of fat and hematopoietic elements, it is sometimes challenging to differentiate AML from adrenocortical carcinoma (ACC). MicroRNAs have been identified as promising biomarkers in many tumors, including adrenocortical neoplasms, but the microRNA expression of adrenal myelolipoma has not been investigated, ...

ea0056p125 | Endocrine tumours and neoplasia | ECE2018

Heterogeneous genetic background of Hungarian patients with pheochromocytoma/paraganglioma requires gene panel testing

Sarkadi Balazs , Zakarias Sara , Liko Istvan , Grolmusz Vince Kornel , Butz Henriett , Toth Miklos , Szucs Nikolette , Igaz Peter , Patocs Attila

Introduction: Pheochromocytomas and paragangliomas (Pheo/PGL) are rare neuroendocrine tumours arising from the adrenal medulla or the symphathetic paraganglia, respectively. Germline mutations are present in ~40% of the patients. To date, at least 16 genes have been demonstrated to be involved in the genetic background of Pheo/PGL. Prioritization in order of genes tested can be applied, but if the probability of a disease-associated germline mutation exceeds 10% the testing of...

ea0056p779 | Pituitary - Basic | ECE2018

Next generation sequencing for characterization of mitochondrial genome in pituitary adenomas

Nemeth Kinga , Darvasi Otto , Liko Istvan , Szucs Nikolette , Czirjak Sandor , Reiniger Lilla , Szabo Borbala , Igaz Peter , Patocs Attila , Butz Henriett

Introduction: Disrupted mitochondrial functions and genetic variations of mitochondrial DNA (mtDNA) have been observed in different tumors. Regarding pituitary adenomas mtDNA was evaluated only in oncocytic type using PCR based methods and it showed high prevalence of Complex I variants. Next generation sequencing (NGS) allows high throughput sequencing and it is useful for accurate identification of heteroplasmy of mitochondrial genome as well.Aim: We a...